<prompt> Please answer with one of the option in the bracket. Write reasoning in between . Write answer in between .Q:A scientist is studying mechanisms by which cancer drugs work to kill tumor cells. She is working to optimize the function of a drug class in order to reduce toxicity and increase potency for the target. After synthesizing a variety of analogs for the drug class, she tests these new pharmacologic compounds against a panel of potential targets. Assay results show that there is significant binding to a clustered group of proteins. Upon examining these proteins, she finds that the proteins add a phosphate group to an aromatic amino acid sidechain. Which of the following disorders would most likely be treated by this drug class?? A: Brain tumors, B: HER2 negative breast cancer, C: Chronic myeloid leukemia, D: Testicular cancer, E: Non-Hodgkin lymphoma,  <response>: This is a question about identifying the disease that would be treated by a drug that targets proteins involved in phosphorylating aromatic amino acid side chains. To answer this, we need to think about which diseases involve dysregulated proteins with this function. The key clues are that the proteins add phosphate groups to aromatic amino acid side chains. This suggests the proteins are tyrosine kinases, and a drug inhibiting them could treat cancers driven by hyperactive tyrosine kinase signaling.C: Chronic myeloid leukemia 